i

iECURE, inc.

17 employees

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Genetics

Date founded

2012

Funding rounds raised

Total raised

$65M

from 6 investors over 6 rounds

i

iECURE, inc. raised $65M on November 30, 2022

Investors: LYFE Capital, Versant Ventures, OrbiMed Advisors and Novo Holdings

i

iECURE, inc. raised $50M on September 9, 2021

Investors: OrbiMed Advisors and Versant Ventures

FAQ